preservatives - potassium sorbate, sodium benzoate
Challenges and strategies for moving patients to injectable medications
In a trial of patients with T2DM and a BMI of 27 kg/m2 or greater being treated with semaglutide injection for weight loss, clinically significant hypoglycemia (plasma glucose less than 54 mg/dL) was reported in 6.2% of semaglutide-treated patients versus 2.5% of placebo-treated patients
Therefore, the use of NSAIDs is usually associated with damage to the gastrointestinal tract and other systems during treatment, and thus need to be used with caution (95)
For quantitative synthesis, effect estimates were collected when available, including HRs, 95% CI, and associated p-values
ACS Appl Mater interfaces